Get started
Author

Juan Navarro Morón

Observed names: J. Navarro Morón, Juan Navarro Moron, Juan Navarro-Moron, Juan Navarro-Morón, Juan Navarro‐Morón
Observed institutions: Institució Catalana de Recerca i Estudis Avançats, Universitat Autònoma de Barcelona, Hospital Sant Joan de Déu Barcelona, Witten/Herdecke University, Hospital de Sant Pau, Hospital Costa del Sol, Complejo Hospitalario de Navarra, Hospital San Pedro de Alcántara, Hospital Infantil Universitario Niño Jesús, Hospital Clínic de Barcelona, Hospital Universitario de Neiva, Hospital Universitario Central de Asturias, Servicio de Salud de Castilla La Mancha, Hospital Universitario Virgen del Rocío, Hospital Universitari Germans Trias i Pujol, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, University of Pennsylvania
OpenAlex ID: A5087721372
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis
2018 · Thaís Armangue, Marianna Spatola, et al. · The Lancet Neurology · 660
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
2020 · Thaís Armangue, Gemma Olivé-Cirera, et al. · The Lancet Neurology · 334
Autoimmune post–herpes simplex encephalitis of adults and teenagers
2015 · Thaís Armangue, Germán Moris, et al. · Neurology · 273
PDF
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma
2021 · Antonio Nieto García, Teresa Garriga‐Baraut, et al. · Pediatric Allergy and Immunology · 37
PDF
Clinical Outcomes of a Zika Virus Mother–Child Pair Cohort in Spain
2020 · Antoni Soriano-Arandes, Marie Antoinette Frick, et al. · Pathogens · 8
PDF
Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain
2023 · María Nieto‐Cid, Teresa Garriga‐Baraut, et al. · Pediatric Allergy and Immunology · 6
Foetal disruptive brain injuries: Diagnosing the underlying pathogenetic mechanisms with cranial ultrasonography
2025 · Ana Alarcón, Nuria Carreras, et al. · Developmental Medicine & Child Neurology · 4
PDF
Delayed-Onset of Multiple Cutaneous Infantile Hemangiomas Due to Propranolol: A Case Report
2015 · Rocío Porcel Chacón, Javier del Boz González, et al. · PEDIATRICS · 4
Cost-effectiveness of Omalizumab for the Treatment of Severe Pediatric Allergic Asthma- Results of a Real-life Study in Spain
2023 · Antonio Nieto, María Nieto-Cid, et al. · 1
PDF
Evaluation of omalizumab to mepolizumab switch in children and adolescents with severe allergic eosinophilic asthma
2025 · Latika Gupta, Ines De Mir Messa, et al.
Mepolizumab treatment in children and adolescents with severe eosinophilic asthma (CASAM)-A real-world study: 12 months analysis
2025 · Latika Gupta, Ines De Mir Messa, et al.
Unusual schistosomiasis presentation and challenges in non-endemic regions
2025 · Clara Carreras-Abad, Èlia Domènech, et al. · Journal of Tropical Pediatrics
Mepolizumab Treatment in Children and Adolescents With Severe Eosinophilic Asthma (CASAM)-A Real-world Study: 12 Months Analysis
2025 · L. Gupta, I. de Mir Messa, et al. · American Journal of Respiratory and Critical Care Medicine
Late Breaking Abstract - Mepolizumab treatment in children and adolescents with severe eosinophilic asthma (CASAM)-A real-world study:initial analysis
2024 · Latika Gupta, Ines De Mir Messa, et al.
Author response for "Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma"
2021 · Antonio Nieto García, Teresa Garriga‐Baraut, et al.
Works count: 15
Citation count: 1,327
H-index: 6
I10-index: 4
Year
Topic
Type